World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
61566
World Ranking
3709
National Ranking
2042

Overview

Richard Simon is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Statistics and Probability, Speech and Hearing, and Mathematical Physics.

The scientist's work covers a range of main topics including:

  • Cystic Fibrosis Research Advances
  • Tracheal and airway disorders
  • Inhalation and Respiratory Drug Delivery
  • Gut microbiota and health
  • Statistical Methods in Clinical Trials
  • Dysphagia Assessment and Management
  • Pharmaceutical studies and practices

Richard Simon has published extensively, with frequent appearances in several key journals. The most common venues for their publications are:

  • Journal of Cystic Fibrosis
  • Statistics in Biopharmaceutical Research
  • Thorax
  • mSystems
  • Journal of Clinical & Translational Endocrinology

Notable papers by Richard Simon include:

  • "Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease," 2020, Journal of Cystic Fibrosis
  • "Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome," 2020, Thorax
  • "Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination," 2020, mSystems
  • "Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion," 2021, Statistics in Biopharmaceutical Research
  • "Coronary artery disease in patients with cystic fibrosis - A case series and review of the literature," 2022, Journal of Clinical & Translational Endocrinology

The scientist has collaborated frequently with a group of co-authors, reflecting interdisciplinary and team-based research efforts. Frequent co-authors include:

  • John J. LiPuma
  • Lisa A. Carmody
  • Linda M. Kalikin
  • Lindsay J. Caverly
  • Rajeshwari Sridhara

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

    Stuart J. Pocock;Richard Simon

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Prediction error estimation: a comparison of resampling methods

    Annette M. Molinaro;Richard Simon;Ruth M. Pfeiffer

  • Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.

    Andreas Rosenwald;Ash A. Alizadeh;George Widhopf;Richard Simon

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

    Richard M. Simon;Soonmyung Paik;Daniel F. Hayes

  • Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.

    Qing Hai Ye;Lun Xiu Qin;Marshonna Forgues;Ping He

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Cystic Fibrosis Adult Care: Consensus Conference Report

    James R. Yankaskas;Bruce C. Marshall;Beth Sufian;Richard H. Simon

  • Randomized clinical trials. Perspectives on some recent ideas.

    David P. Byar;Richard M. Simon;William T. Friedewald;James J. Schlesselman

  • Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

    Daniel T. Eitzman;Ronald D. McCoy;Xianxian Zheng;William P. Fay

  • Gene Expression Profiling of Alveolar Rhabdomyosarcoma with cDNA Microarrays

    Javed Khan;Richard Simon;Michael Bittner;Yidong Chen

  • Confidence Intervals for Reporting Results of Clinical Trials

    Richard Simon

  • Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.

    Thomas H. Sisson;Michael Mendez;Karen Choi;Natalya Subbotina

  • Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

    Silvia Bea;Andreas Zettl;George Wright;Itziar Salaverria

  • A neural network model for survival data.

    David Faraggi;Richard Simon

  • Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

    John P. Chute;Timothy Chen;Ellen Feigal;Richard Simon

  • Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

    Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton

Frequent Co-Authors

Clemencia Pinilla
Clemencia Pinilla Florida International University
Edward L. Korn
Edward L. Korn National Institutes of Health
Roland Martin
Roland Martin University of Zurich
Marc Peters-Golden
Marc Peters-Golden University of Michigan–Ann Arbor
Marc E. Lippman
Marc E. Lippman National Institutes of Health
Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
Baris Turkbey
Baris Turkbey National Institutes of Health
James H. Doroshow
James H. Doroshow National Institutes of Health
Peter F. Thall
Peter F. Thall The University of Texas MD Anderson Cancer Center
Peter L. Choyke
Peter L. Choyke National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative education pathways in medicine can be a smart choice for many students. Online programs now offer flexible options to advance your healthcare career beyond traditional routes. For example, if you are a registered nurse aiming for leadership roles, check out some of the most affordable dnp programs available online.

Those interested in pharmaceuticals may want to consider accredited online pharmd programs, which can open doors to clinical and research roles in pharmacy practice.

If your strengths lie with information management or health records, pursuing online rhit degree programs could lead to rewarding roles in health information technology.

For those seeking a quick entry into the medical field, you might look at medical billing and coding online courses cost to evaluate cost-effective certificate options. These programs can prepare you for in-demand positions in medical billing and coding. Online healthcare degrees provide diverse, affordable ways to build your career in medicine.

Best Scientists Citing Richard Simon

Trending Scientists